AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: http://hdl.handle.net/11055/822
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHayes Cen_US
dc.contributor.authorArmstrong-Brown Aen_US
dc.contributor.authorBurstal Ren_US
dc.date.accessioned2018-12-14T02:06:22Z-
dc.date.available2018-12-14T02:06:22Z-
dc.date.issued2004-
dc.identifier.citation32(3):330-8.en_US
dc.identifier.urihttp://hdl.handle.net/11055/822-
dc.description.abstractWe hypothesized that perioperative ketamine administration would modify acute central sensitization following amputation and hence reduce the incidence and severity of persistent post-amputation pain (both phantom limb and stump pain). In a randomized, controlled trial, 45 patients undergoing above- or below-knee amputation received ketamine 0.5 mg x kg(-1) or placebo as a pre-induction bolus followed by an intravenous infusion of ketamine 0.5 mg x kg(-1) x h(-1) or normal saline for 72 hours postoperatively. Both groups received standardized general anaesthesia followed by patient-controlled intravenous morphine. The surface area of allodynia over the stump was mapped at days 3 and 6. Postamputation pain was assessed at days 3 and 6 and at 6 months postoperatively. We found no significant difference between groups in the surface area of stump allodynia or in morphine consumption. There was an unexplained, but significant, increase in the incidence of stump pain in the ketamine group at day 3. At six-month review, the incidence of phantom pain was 47% in the ketamine group and 71% in the control group. This did not reach statistical significance (P=0.28) as the power of the study was based on the search for a large treatment effect. The incidence of stump pain at six months was 47% in the ketamine group and 35% in the control group (P=0.72). There were no significant between-group differences in pain severity throughout the study period. Ketamine at the dose administered did not significantly reduce acute central sensitization or the incidence and severity of post-amputation pain.en_US
dc.subjectcentral nervous system sensitizationen_US
dc.subjectamputationen_US
dc.subjectinfusions, intravenousen_US
dc.subjecthyperalgesiaen_US
dc.subjectamputation stumpsen_US
dc.subjectanesthesia, generalen_US
dc.titlePerioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: a randomised, controlled trialen_US
dc.typeJournal Articleen_US
dc.type.contentTexten_US
dc.identifier.journaltitleAnaesthesia and Intensive Careen_US
dc.type.studyortrialClinical Trialen_US
dc.contributor.anzcaHayes, Cen_US
Appears in Collections:Scholarly and Clinical

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.